In the tumour cells that reside post treatment, 40 candidates were found to have increased expression alongside enriched accessible binding motifs, including TP63, TCF4 and the well-defined regulator of OC cancer stem-cell differentiation, TWIST131. The gene discussed is TCF4; the disease is neoplasm.